Tumor Treating Fields Combine with Temozolomide for Newly Diagnosed Glioblastoma: A Retrospective Analysis of Chinese Patients in a Single Center

Introduction: TTFields plus Temozolomide (TTFields/TMZ) extended survival versus TMZ alone in newly diagnosed glioblastoma (GBM) patients in the EF-14 trial. We have reported a retrospective analysis of newly diagnosed Chinese GBM patients who received TTFields/TMZ treatment and TMZ treatment from A...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Chunjui, Xu, Hao, Song, Kun, Zhang, Yi, Zhang, Junyan, Wang, Yang, Sheng, Xiaofang, Chen, Lingchao, Qin, Zhiyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9570572/
https://www.ncbi.nlm.nih.gov/pubmed/36233722
http://dx.doi.org/10.3390/jcm11195855

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9570572/
https://www.ncbi.nlm.nih.gov/pubmed/36233722
http://dx.doi.org/10.3390/jcm11195855

Ejemplares similares